Vertero Therapeutics
Latest round
- Series D
Last raised
- Jan 2025
Total raised
- $81M
Investors
- 9
About Vertero Therapeutics
, formerly known as Axial Therapeutics, specializes in therapeutics that leverage the gut-brain axis. In October 2025, Vertero Therapeutics, Inc. Vertero Therapeutics specializes in the development of innovative small molecule therapeutics targeting the gut microbiome to address diseases and disorders such as autism spectrum disorder (ASD), Parkinson’s disease, liver disease, and oncology. Their lead product candidate, AB-2004, is aimed at treating irritability associated with autism and is currently in a global, randomized, placebo-controlled Phase 2 clinical trial, with results expected in Q1 2024. The company is also advancing its Microbial-Inspired Therapeutics® Platform, which explores the relationship between the microbiome and the nervous system to create transformative therapeutics, primarily targeting healthcare providers in North America and Europe.
Who invested in Vertero Therapeutics
9 investors across 5 rounds
See all investors in Vertero Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vertero Therapeutics
Who invested in Vertero Therapeutics?
Vertero Therapeutics has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vertero Therapeutics raised?
Vertero Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Vertero Therapeutics last raise money?
Vertero Therapeutics's most recent round on record is a Series D, in Jan 2025.
What does Vertero Therapeutics do?
, formerly known as Axial Therapeutics, specializes in therapeutics that leverage the gut-brain axis.
Where is Vertero Therapeutics headquartered?
Vertero Therapeutics is headquartered in Woburn, US.
Which VCs invest in companies like Vertero Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vertero Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Vertero Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.